أخبار السوق

تابع أحدث الأخبار المالية والاقتصادية وتحديثات الأسواق والتقارير والتحليلات على PipVero.

المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Ulta Beauty (ULTA) Increases Yet Falls Behind Market: What Investors Need to Know

Ulta Beauty (ULTA) Increases Yet Falls Behind Market: What Investors Need to Know

In the closing of the recent trading day, Ulta Beauty (ULTA) stood at $543.86, denoting a +1.77% move from the preceding trading day.

الرموز ذات الصلة 1
ULTA ULTA
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Toll Brothers (TOL) Exceeds Market Returns: Some Facts to Consider

Toll Brothers (TOL) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Toll Brothers (TOL) settling at $153.24, representing a +1.85% change from its previous close.

الرموز ذات الصلة 1
TOL TOL
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Oracle (ORCL) Outpaces Stock Market Gains: What You Should Know

Oracle (ORCL) Outpaces Stock Market Gains: What You Should Know

In the closing of the recent trading day, Oracle (ORCL) stood at $145.74, denoting a +2.74% move from the preceding trading day.

الرموز ذات الصلة 1
ORCL ORCL
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Why Gold.com (GOLD) Outpaced the Stock Market Today

Why Gold.com (GOLD) Outpaced the Stock Market Today

The latest trading day saw Gold.com (GOLD) settling at $42.9, representing a +1.83% change from its previous close.

الرموز ذات الصلة 1
GOLD GOLD
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Intuit (INTU) Advances But Underperforms Market: Key Facts

Intuit (INTU) Advances But Underperforms Market: Key Facts

In the closing of the recent trading day, Intuit (INTU) stood at $323.6, denoting a +1.64% move from the preceding trading day.

الرموز ذات الصلة 1
INTU INTU
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Home Depot (HD) Surpasses Market Returns: Some Facts Worth Knowing

Home Depot (HD) Surpasses Market Returns: Some Facts Worth Knowing

Home Depot (HD) concluded the recent trading session at $348.24, signifying a +2.42% move from its prior day's close.

الرموز ذات الصلة 1
HD HD
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Seeking Alpha وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
SpaceX Q2: A Monster Beat, A Broken Valuation (Strong Sell)

SpaceX Q2: A Monster Beat, A Broken Valuation (Strong Sell)

Space Exploration Technologies Corp. aka SpaceX delivered a spectacular Q2, with $7.81B in revenue and $3.54B in adjusted EBITDA, beating expectations across nearly every major business line. Yet SPCX stock fell about 8% after earnings. Investors were not questioning the growth; they were questioning how much capital SpaceX must spend to produce it. Starlink remains the economic engine of the group, generating $4.29B in revenue and $1.66B in operating profit while AI and Space posted combined operating losses of roughly $1.80B.

الرموز ذات الصلة 1
SPCX SPCX
المصدر: Seeking Alpha
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates

Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates

Syndax Pharmaceuticals (SNDX) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to a loss of $0.83 per share a year ago.

الرموز ذات الصلة 1
SNDX SNDX
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates

Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates

Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.88 per share, missing the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $3.28 per share a year ago.

الرموز ذات الصلة 1
RIGL RIGL
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Personalis (PSNL) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.23 per share a year ago.

الرموز ذات الصلة 1
PSNL PSNL
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Lumen (LUMN) Reports Q2 Loss, Tops Revenue Estimates

Lumen (LUMN) Reports Q2 Loss, Tops Revenue Estimates

Lumen (LUMN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.03 per share a year ago.

الرموز ذات الصلة 1
LUMN LUMN
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Allegiant Travel (ALGT) Q2 Earnings Beat Estimates

Allegiant Travel (ALGT) Q2 Earnings Beat Estimates

Allegiant Travel (ALGT) came out with quarterly earnings of $2.19 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.23 per share a year ago.

الرموز ذات الصلة 1
ALGT ALGT
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Gilead Sciences (GILD) Reports Q2 Loss, Beats Revenue Estimates

Gilead Sciences (GILD) Reports Q2 Loss, Beats Revenue Estimates

Gilead Sciences (GILD) came out with a quarterly loss of $6.75 per share versus the Zacks Consensus Estimate of a loss of $7.07. This compares to earnings of $2.01 per share a year ago.

الرموز ذات الصلة 1
GILD GILD
المصدر: Zacks Investment Research
زيارة المصدر
تعليق